Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
Daniela Elgueta
Observed names:
Elgueta Daniela,
Elgueta, Daniela
Institution:
Fundación Ciencia and Vida
Observed institutions:
Universidad Mayor,
Universidad Andrés Bello,
Pontificia Universidad Católica de Chile,
Fundación Ciencia and Vida
OpenAlex ID:
A5062759064
Works
19
Awards
1
Neuroimmune regulation of microglial activity involved in neuroinflammation and neurodegenerative diseases
2014
·
Hugo González
, Daniela Elgueta
, et al.
·
Journal of Neuroimmunology
·
394
T-Cell-Driven Inflammation as a Mediator of the Gut-Brain Axis Involved in Parkinson's Disease
2019
·
Javier Campos-Acuña
, Daniela Elgueta
, et al.
·
Frontiers in Immunology
·
158
PDF
Dopamine Receptor D3 Expressed on CD4+ T Cells Favors Neurodegeneration of Dopaminergic Neurons during Parkinson’s Disease
2013
·
Hugo González
, Francisco Contreras
, et al.
·
The Journal of Immunology
·
147
Stimulation of Dopamine Receptor D5 Expressed on Dendritic Cells Potentiates Th17-Mediated Immunity
2012
·
Carolina Prado
, Francisco Contreras
, et al.
·
The Journal of Immunology
·
141
Dopamine receptor D3 signalling in astrocytes promotes neuroinflammation
2019
·
Andro Montoya
, Daniela Elgueta
, et al.
·
Journal of Neuroinflammation
·
86
PDF
Dopamine Receptor D3 Signaling on CD4+ T Cells Favors Th1- and Th17-Mediated Immunity
2016
·
Francisco Contreras
, Carolina Prado
, et al.
·
The Journal of Immunology
·
85
Consequences of Viral Infection and Cytokine Production During Pregnancy on Brain Development in Offspring
2022
·
Daniela Elgueta
, Paola Murgas
, et al.
·
Frontiers in Immunology
·
74
PDF
Pharmacologic antagonism of dopamine receptor D3 attenuates neurodegeneration and motor impairment in a mouse model of Parkinson's disease
2016
·
Daniela Elgueta
, María S. Aymerich
, et al.
·
Neuropharmacology
·
67
Dopamine Receptor D3 Expression Is Altered in CD4+ T-Cells From Parkinson's Disease Patients and Its Pharmacologic Inhibition Attenuates the Motor Impairment in a Mouse Model
2019
·
Daniela Elgueta
, Francisco Contreras
, et al.
·
Frontiers in Immunology
·
61
PDF
Dopamine receptors D3 and D5 regulate CD4+T-cell activation and differentiation by modulating ERK activation and cAMP production
2015
·
Dafne Franz
, Francisco Contreras
, et al.
·
Journal of Neuroimmunology
·
53
The c-Abl/p73 pathway induces neurodegeneration in a Parkinson's disease model
2022
·
Tamara Marín
, Cristian Valls
, et al.
·
IBRO Neuroscience Reports
·
14
Neural conditional ablation of the protein tyrosine phosphatase receptor Delta PTPRD impairs gliogenesis in the developing mouse brain cortex
2024
·
Francisca Cornejo
, Nayhara Franchini
, et al.
·
Frontiers in Cell and Developmental Biology
·
8
PDF
Gestational hypothyroxinemia causes an inflammatory environment at maternal-fetal tissues and fetal brain with impaired hippocampal dendritic spine maturation in the offspring
2025
·
Enrique González-Madrid
, Ma. Andreina Rangel-Ramírez
, et al.
·
Scientific Reports
·
5
PDF
Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
2022
·
Daniela Elgueta
, Ornella Chovar
, et al.
·
Journal of Visualized Experiments
·
5
Dopaminergic signalling through dopamine receptor D2 favours the functional stability of regulatory T cells mitigating gut inflammation and neuroinflammation
2026
·
Jazmín Castro
, José Manuel Jiménez
, et al.
·
Research Square
PDF
Preclinical evaluation of nitrated α-synuclein-specific CAR-Treg therapy in Parkinson’s disease
2026
·
Valentina Ugalde
, Daniela Elgueta
, et al.
·
Cell Reports Medicine
Dopamine receptor D3 expressed on CD4+ T-cells favours neurodegeneration of dopaminergic neurons during Parkinson's disease
2013
·
Pacheco Rodrigo
, Gonzalez Hugo
, et al.
·
Frontiers in Immunology
Show more works
View as search
Works count:
19
Citation count:
1,299
H-index:
11
I10-index:
11
Year
Topic
Type